Skip to main content
. Author manuscript; available in PMC: 2020 Jan 15.
Published in final edited form as: Clin Cancer Res. 2018 Nov 12;25(2):524–532. doi: 10.1158/1078-0432.CCR-18-2258

Figure 1:

Figure 1:

E3611: Study Schema, phase II randomized trial of of ipilimumab at 3 mg/kg or 10 mg/kg alone or in combination with high dose interferon-α in advanced melanoma